Grippol
Instructions for use:
- 1. Release form and composition
- 2. Indications for use
- 3. Contraindications
- 4. Method of application and dosage
- 5. Side effects
- 6. Special instructions
- 7. Drug interactions
- 8. Analogs
- 9. Terms and conditions of storage
- 10. Terms of dispensing from pharmacies
Grippol is a vaccine for the prevention of influenza.
Release form and composition
The dosage form of Grippol is a solution (suspension) for intramuscular and subcutaneous administration with / without a preservative: colorless or slightly yellowish, transparent (in ampoules or syringes of 0.5 mg, in a cardboard box of 1, 5 or 10 ampoules, or in contour cell packs of 1, 5 or 10 syringes / ampoules).
Active substances in 0.5 ml solution (1 dose):
- hemagglutinin of influenza virus type A (strain H3N2) - 0.005 mg;
- hemagglutinin of influenza virus type A (strain H1N1) - 0.005 mg;
- hemagglutinin of influenza virus type B - 0.011 mg;
- polyoxidonium (azoxymer bromide) - 0.5 mg.
An auxiliary component in the vaccine with a preservative: merthiolate (thiomersal) - 0.05 ± 0.0075 mg.
Depending on the epidemic situation, the antigenic composition of the strains changes annually (in accordance with the recommendations of the WHO and the Commission on influenza vaccine and diagnostic strains of the Russian Ministry of Health).
Indications for use
Grippol is prescribed for active prophylactic immunization against influenza in patients from six months of age, including the elderly over 60 years old, schoolchildren and preschool children, transport workers, service workers, educational institutions, military personnel, medical workers, people who suffer from chronic somatic diseases or often suffer from acute respiratory diseases.
Contraindications
Absolute:
- exacerbation of a chronic disease;
- febrile conditions in an acute course;
- age up to 6 months (vaccine without a preservative) or 18 years (vaccine with a preservative);
- pregnancy period (vaccine with a preservative);
- individual intolerance to the components of the drug, as well as allergic reactions to chicken protein and previous vaccinations.
Relative (diseases / conditions in which the use of Grippol requires caution):
- mild acute respiratory viral infections, acute intestinal diseases (administration of the drug is possible after normalization of temperature);
- the period of pregnancy (vaccine without preservatives; the decision to prescribe Grippol is made by the doctor based on the degree of risk of influenza infection and the likely complications of influenza infection; II – III trimesters of pregnancy are the safest for vaccination).
Method of administration and dosage
The method of administration of Grippol is intramuscularly or deeply subcutaneously into the deltoid muscle (the upper third of the outer surface of the shoulder), for young children - into the antero-outer surface of the thigh.
Intravenous administration of Grippol is prohibited.
Vaccination is recommended in the autumn-winter period annually or at the beginning of an epidemic rise in the incidence of influenza.
Recommended doses:
- children from 3 years old and adults (no age limit): 0.5 ml once;
- children from 6 months to 3 years: twice with an interval between injections of 4 weeks, 0.25 ml; in cases where the child was vaccinated against influenza in the previous season - once, 0.5 ml.
Patients with immunodeficiency Grippol can be injected twice: 0.5 ml with a break between injections for 4 weeks.
The vaccination procedure, including opening the ampoules, must be carried out in strict observance of antiseptic / aseptic rules. Do not store the drug in an opened ampoule.
Side effects
- systemic reactions: extremely rarely - weakness, headache, malaise, low-grade fever (usually go away on its own after 1-2 days); in extremely rare cases - allergic reactions (usually in the presence of high individual sensitivity);
- local reactions: very rarely - redness, swelling and soreness of the skin.
special instructions
Vaccination rooms should contain medications necessary for stopping anaphylactic reaction and carrying out anti-shock measures. Within 30 minutes after the administration of Grippol, it is necessary to monitor the patient's condition.
Before the introduction of the drug, the vaccinated person must be examined by a doctor with mandatory thermometry. A temperature above 37 ° C is a contraindication for drug administration.
If the integrity or labeling of the package is violated, the physical properties of the drug change, the expiration date or the requirements for storage conditions are violated, Grippol cannot be used.
Drug interactions
Grippol can be administered during the basic treatment of the underlying disease.
It should be borne in mind that vaccination of patients who receive immunosuppressive therapy may be less effective.
Grippol can be used simultaneously with other inactivated vaccines, taking into account the contraindications to each of the vaccines used. You need to inject drugs with different syringes in different parts of the body.
Analogs
Grippol's analogues are: Grippol plus, MonoGrippol, MonoGrippol Neo and others.
Terms and conditions of storage
Store at 2-8 ° C. Keep out of the reach of children. Do not freeze.
Expiration date - 1 year.
It is possible to transport Grippol for 6 hours at temperatures up to 25 ° C.
Terms of dispensing from pharmacies
Dispensed by prescription.
Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!
